Published in Clin Exp Immunol on August 01, 1992
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol (1994) 2.18
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A (1999) 1.72
The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology (2001) 1.49
Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci U S A (1994) 1.42
The role of T helper type 17 cells in inflammatory arthritis. Clin Exp Immunol (2009) 1.03
Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA) Clin Exp Immunol (1995) 1.00
Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interferon Cytokine Res (2011) 1.00
Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology (1995) 0.98
The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br J Pharmacol (1994) 0.97
Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen. Clin Exp Immunol (2002) 0.90
Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol (1993) 0.89
Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus. BMC Complement Altern Med (2007) 0.82
Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis : a therapeutic study using a macrophage-deactivating compound. Am J Pathol (2001) 0.81
Accelerated onset of collagen-induced arthritis by remote inflammation. Clin Exp Immunol (1994) 0.80
Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human/murine SCID arthritis. Ann Rheum Dis (1999) 0.78
Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis. Br J Pharmacol (1999) 0.78
Staphylococcal enterotoxin B increases the severity of type II collagen induced arthritis in mice. Ann Rheum Dis (1995) 0.78
Role of cytokines in experimental arthritis. Clin Exp Immunol (1994) 0.77
Influence of long term silicone implantation on type II collagen induced arthritis in mice. Ann Rheum Dis (1999) 0.77
Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis. Arthritis Res Ther (2016) 0.75
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med (1986) 10.91
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J (1991) 8.31
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med (1985) 8.16
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol (1986) 5.19
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum (1990) 4.39
Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods (1984) 4.27
Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol (1987) 3.41
Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum (1991) 3.35
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A (1991) 3.19
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy Appl Immunol (1969) 2.92
Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol (1988) 2.80
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum (1988) 2.77
Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum (1983) 2.75
Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest (1987) 2.74
Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med (1989) 2.69
Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med (1987) 2.42
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med (1990) 2.19
Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest (1989) 2.18
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest (1989) 2.13
Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09
Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest (1987) 2.06
In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol (1988) 1.85
Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med (1989) 1.77
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Heterogeneous effects of IFN-gamma in adjuvant arthritis. J Immunol (1989) 1.12
Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage. J Clin Invest (1991) 1.10
Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction. Clin Exp Immunol (1991) 1.07
Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum (1981) 0.97
Interleukin 1 enhances the development of spontaneous arthritis in MRL/lpr mice. Clin Immunol Immunopathol (1990) 0.89
Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity. J Lab Clin Med (1989) 0.85
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science (1993) 3.30
Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol (1996) 3.19
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64
Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29
Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. J Biol Chem (1984) 2.21
Collagen-induced arthritis, an animal model of autoimmunity. Life Sci (1997) 2.20
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10
Fibronectin-associated transforming growth factor. J Cell Physiol (1987) 1.89
Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity (1995) 1.85
Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71
Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver. Proc Natl Acad Sci U S A (1982) 1.70
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55
Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52
The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein. J Clin Invest (1971) 1.51
Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51
Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49
Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48
Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43
Topics in clinical medicine. Complement levels in disease. Johns Hopkins Med J (1967) 1.29
Internalization of functional epidermal growth factor:receptor/kinase complexes in A-431 cells. J Biol Chem (1985) 1.28
Indeterminate human immunodeficiency virus type 1 western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J Infect Dis (1991) 1.24
Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21
Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol (1999) 1.19
Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science (1982) 1.16
Preliminary criteria for the classification of systemic lupus erythematosus (SLE). Evaluation in early diagnosed SLE and rheumatoid arthritis. Arthritis Rheum (1974) 1.16
Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum (1987) 1.14
Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med (1988) 1.12
Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12
Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med (1975) 1.09
Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol (1983) 1.04
Controlled trial of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum (1976) 1.04
Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol (1994) 1.04
Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol (1976) 0.98
Type II collagen-induced autoimmune otospongiosis. A preliminary report. Ann Otol Rhinol Laryngol (1983) 0.97
Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum (1981) 0.97
The role of collagen autoimmunity in animal models and human diseases. J Invest Dermatol (1982) 0.95
Induction by chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide. Br J Rheumatol (1996) 0.95
Purification of the FLP site-specific recombinase by affinity chromatography and re-examination of basic properties of the system. Nucleic Acids Res (1987) 0.93
Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum (1986) 0.93
Arthritis in viral hepatitis. Report of two cases and review of the literature. Johns Hopkins Med J (1973) 0.92
Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol (1993) 0.89
Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies. Springer Semin Immunopathol (1998) 0.89
Complement in synovial fluid. Johns Hopkins Med J (1970) 0.89
Infection with Mycoplasma pulmonis modulates adjuvant- and collagen-induced arthritis in Lewis rats. Arthritis Rheum (1984) 0.89
Complement-fixing activity of rheumatoid synovial fluid. Ann Rheum Dis (1972) 0.88
Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig. J Immunol (1976) 0.88
Analysis of type II collagen reactive T cells in the mouse. II. Different localization of immunodominant T cell epitopes on heterologous and autologous type II collagen. Scand J Immunol (1991) 0.86
Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis Rheum (1999) 0.86
Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice. Immunology (1998) 0.86
The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: possible cross-reaction of antibodies to dietary collagens with autologous type II collagen. Clin Immunol Immunopathol (1996) 0.86
Monoclonal antibodies against bovine type IX collagen (LMW fragment): production, characterization, and use for immunohistochemical localization studies. J Histochem Cytochem (1991) 0.85
Lipocortin-independent effect of dexamethasone on phospholipase activity in a thymic epithelial cell line. Biochem J (1989) 0.85
Partial dissociation of rheumatoid synovial fluid cryoprotein: micro-complement fixation by IgG- or IgG and IgM-containing fractions and denatured calf thymus DNA. J Immunol (1971) 0.84
Type II collagen-induced arthritis. Ann N Y Acad Sci (1985) 0.84
Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis. Clin Exp Immunol (1990) 0.84
Immunogenetics of collagen-induced arthritis in rats. Both MHC and non-MHC gene products determine the epitope specificity of immune response to bovine and chick type II collagens. J Immunol (1992) 0.83
Proceedings: Impaired cell-mediated immunity in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Arthritis Rheum (1974) 0.83
Physicochemical and immunological studies of the renatured alpha 1(II) chains and isolated cyanogen bromide peptides of type II collagen. Coll Relat Res (1985) 0.82
The effect of diltiazem on calcinosis in a patient with the CREST syndrome. Arthritis Rheum (1990) 0.81
The roles of interleukin-18 in collagen-induced arthritis in the BB rat. Clin Exp Immunol (2004) 0.81
Collagen-induced arthritis in rodents. A review of clinical, histological and immunological features. Ryumachi (1984) 0.81
The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis. Immunology (1988) 0.81
Identification of Neisseria gonorrhoeae in synovial membrane by electron microscopy. J Infect Dis (1974) 0.81
Letter: Cause of adult toxic epidermal necrolysis. N Engl J Med (1975) 0.79
Immunogenicity of recombinant type IX collagen in murine collagen-induced arthritis. Arthritis Rheum (2002) 0.79
Evidence for preferential T cell receptor V beta gene usage and T cell clonal expansion in the synovium of BB rats with early-onset collagen-induced arthritis. Cell Immunol (1998) 0.79
Autoantibodies to type II collagen. Mayo Clin Proc (1984) 0.79
Collagen-induced arthritis in rats. Assessment by serial magnification radiography. Invest Radiol (1985) 0.78
Lymphocyte surface markers in human disease. Adv Intern Med (1977) 0.78
Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat. Prostate (1993) 0.78
Immunopathogenic mechanisms in type II collagen autoimmune arthritis. Pathol Immunopathol Res (1986) 0.77
Type II collagen distribution in the ear of the guinea pig fetus. Ann Otol Rhinol Laryngol (1989) 0.76
Specific membrane receptors for diferric-transferrin in cultured rat skeletal myocytes and chick-embryo cardiac myocytes. Biosci Rep (1981) 0.76
Failure of calcitonin to inhibit collagen-induced arthritis in rats. Agents Actions (1982) 0.76
The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances. Clin Exp Immunol (2007) 0.75
Total lymphoid irradiation retards evolution of articular erosions in collagen induced arthritis. J Rheumatol (1988) 0.75
The role of epidermal growth factor in skin diseases. Am J Med Sci (1988) 0.75
Analysis of dimethyl sulfoxide immunosuppression in the rat model of collagen II autoimmune arthritis: an effect dependent upon intraperitoneal administration and associated with toxicity. Agents Actions (1985) 0.75
Alkaline phosphatase activity of synovial leukocytes. Johns Hopkins Med J (1971) 0.75